Tyche Industries (BSE 532384)₹106.78+3.13%Pharmaceuticals
In the Mar 2026 quarter (standalone), Tyche Industries reported sales of ₹16.27 Cr, up 31.0% from Mar 2025, and net profit of ₹1.16 Cr, up 22.1% year on year. For the year to Mar 2026, sales were ₹53.85 Cr and net profit ₹6.95 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.11 | 16.11 | 22.32 | 14.24 | 15.58 | 20.63 | 17.81 | 12.42 | 12.74 | 14.21 | 10.63 | 16.27 |
| Expenses | 14.23 | 12.89 | 17.37 | 12.29 | 12.88 | 15.79 | 12.90 | 12.52 | 10.74 | 14.25 | 9.47 | 16.84 |
| Operating Profit | 2.79 | 3.12 | 4.82 | 1.87 | 2.61 | 4.71 | 4.81 | −0.17 | 1.93 | −0.12 | 1.08 | −0.66 |
| OPM % | 16.4% | 19.5% | 21.8% | 13.2% | 16.9% | 23.0% | 27.2% | −1.5% | 15.3% | −0.9% | 10.3% | −4.2% |
| Other Income | 1.28 | 1.52 | 1.50 | 1.58 | 1.51 | 1.13 | 2.03 | 2.00 | 1.76 | 2.64 | 1.84 | 2.95 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.45 | 0.46 | 0.47 | 0.53 | 0.48 | 0.48 | 0.49 | 0.49 | 0.44 | 0.46 | 0.47 | 0.58 |
| Profit before tax | 3.62 | 4.17 | 5.83 | 2.92 | 3.64 | 5.35 | 6.34 | 1.32 | 3.25 | 2.04 | 2.45 | 1.69 |
| Tax % | 25.1% | 25.4% | 26.8% | 28.7% | 24.9% | 25.5% | 25.8% | 28.6% | 25.5% | 25.9% | 26.0% | 31.8% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 2.72 | 3.15 | 4.30 | 2.11 | 2.74 | 4.00 | 4.75 | 0.95 | 2.44 | 1.53 | 1.83 | 1.16 |
| EPS (Rs) | 2.63 | 3.05 | 4.18 | 2.04 | 2.65 | 3.88 | 4.61 | 0.91 | 2.36 | 1.47 | 1.77 | 1.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.32 | 42.80 | 51.83 | 54.18 | 73.98 | 78.52 | 62.51 | 75.65 | 69.73 | 65.73 | 53.85 | 53.85 |
| Expenses | 51.07 | 36.54 | 42.50 | 44.69 | 52.25 | 53.43 | 51.19 | 59.17 | 56.74 | 54.05 | 51.29 | 51.30 |
| Operating Profit | 2.91 | 5.97 | 9.01 | 9.14 | 21.33 | 24.67 | 10.93 | 16.11 | 12.62 | 11.26 | 2.23 | 2.23 |
| OPM % | 5.4% | 14.1% | 17.5% | 17.0% | 29.0% | 31.6% | 17.6% | 21.4% | 18.2% | 17.3% | 4.2% | 4.1% |
| Other Income | 1.67 | 1.88 | 1.68 | 2.51 | 3.67 | 3.74 | 3.45 | 4.70 | 5.91 | 7.41 | 9.21 | 9.19 |
| Interest | 0.30 | 0.09 | 0.02 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.75 | 1.86 | 1.84 | 1.83 | 1.73 | 1.71 | 1.78 | 1.76 | 1.93 | 1.98 | 1.99 | 1.95 |
| Profit before tax | 2.54 | 5.90 | 8.82 | 9.81 | 23.24 | 26.64 | 12.59 | 19.03 | 16.56 | 16.66 | 9.42 | 9.43 |
| Tax % | 3.5% | 48.1% | 33.9% | 27.5% | 24.8% | 25.3% | 26.1% | 25.7% | 26.5% | 25.8% | 26.8% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | −0.75 | −0.52 | −0.10 | 0.00 | 0.03 | 0.00 | 0.00 |
| Net Profit | 2.48 | 3.09 | 5.88 | 7.16 | 17.58 | 20.01 | 9.35 | 14.20 | 12.26 | 12.44 | 6.95 | 6.96 |
| EPS (Rs) | 2.40 | 2.99 | 5.70 | 6.96 | 17.08 | 19.44 | 9.08 | 13.80 | 11.90 | 12.09 | 6.76 | 6.71 |
| Dividend payout % | 20.8% | 16.7% | 8.8% | 7.2% | 0.0% | 5.2% | 16.6% | 0.0% | 21.0% | 24.9% | 51.8% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.21 | 10.20 | 10.20 | 10.23 | 10.22 | 10.22 | 10.21 | 10.22 | 10.23 | 10.22 | 10.23 | 10.22 |
| Reserves | 33.56 | 35.35 | 37.65 | 42.91 | 50.07 | 66.92 | 85.75 | 93.99 | 107 | 116 | 127 | 130 |
| Borrowings | 8.72 | 10.87 | 0.00 | 0.08 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 11.57 | 11.04 | 13.15 | 13.54 | 13.69 | 17.58 | 21.02 | 16.08 | 19.86 | 7.91 | 10.67 | 7.60 |
| Total Liabilities | 64.06 | 67.46 | 61.00 | 66.76 | 74.03 | 94.72 | 117 | 120 | 137 | 135 | 147 | 148 |
| Fixed Assets | 29.04 | 28.47 | 26.63 | 19.89 | 19.21 | 17.70 | 17.98 | 16.68 | 16.64 | 17.94 | 16.51 | 18.94 |
| CWIP | 0.39 | 0.32 | 0.32 | 0.00 | 0.00 | 0.00 | 0.52 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 34.63 | 38.67 | 34.05 | 46.87 | 54.82 | 77.02 | 98.48 | 104 | 120 | 117 | 131 | 129 |
| Inventories | 12.98 | 4.99 | 3.99 | 4.99 | 7.98 | 9.99 | 10.98 | 10.98 | 17.96 | 12.98 | 16.97 | 9.98 |
| Trade receivables | 16.05 | 16.04 | 9.02 | 10.03 | 10.02 | 13.03 | 17.03 | 16.03 | 22.06 | 19.04 | 17.04 | 20.06 |
| Cash & equivalents | 0.99 | 13.99 | 14.98 | 24.97 | 28.97 | 44.94 | 60.96 | 67.91 | 68.95 | 78.96 | 83.92 | 74.91 |
| Total Assets | 64.06 | 67.46 | 61.00 | 66.76 | 74.03 | 94.72 | 117 | 120 | 137 | 135 | 147 | 148 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 2.30 | 11.90 | 11.33 | 5.02 | 3.74 | 15.14 | 15.40 | 4.44 | 6.40 | 7.68 | 8.51 | 2.84 |
| Cash from investing activity | −0.99 | −1.35 | 0.61 | 6.30 | 0.64 | 2.05 | 0.43 | 3.17 | −3.13 | 3.95 | −0.63 | −8.97 |
| Cash from financing activity | −3.23 | 1.58 | −10.58 | −0.61 | −0.06 | −0.63 | −1.03 | −1.03 | −1.53 | −2.04 | −2.55 | −3.06 |
| Net cash flow | −1.89 | 12.19 | 1.37 | 10.71 | 4.30 | 16.61 | 14.84 | 6.58 | 1.76 | 9.59 | 5.36 | −9.16 |
| Capex | 1.03 | 1.25 | 0.06 | 1.41 | 1.17 | 0.27 | 2.49 | 0.98 | 1.74 | 3.22 | 0.71 | 4.25 |
| Free cash flow | 1.34 | 10.83 | 11.35 | 10.26 | 2.62 | 14.98 | 12.96 | 4.59 | 4.69 | 4.49 | 7.85 | −1.42 |
| CFO / OP % | 33.0% | 409.9% | 189.9% | 56.0% | 41.0% | 71.0% | 61.9% | 41.0% | 40.0% | 61.0% | 75.9% | 127.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 91 | 107 | 81 | 68 | 69 | 64 | 80 | 96 | 107 | 100 | 95 | 133 |
| Inventory days | 139 | 69 | 85 | 86 | 124 | 123 | 149 | 149 | 196 | 158 | 246 | 151 |
| Days payable | 75 | 92 | 130 | 86 | 95 | 90 | 92 | 77 | 133 | 47 | 84 | 37 |
| Cash conversion cycle | 153 | 82 | 34 | 67 | 96 | 94 | 135 | 167 | 168 | 210 | 255 | 245 |
| Working capital days | 77 | 21 | 60 | 67 | 87 | 77 | 83 | 121 | 129 | 144 | 151 | 177 |
| ROCE % | 7.4% | 5.2% | 11.5% | 17.6% | 17.4% | 33.9% | 32.0% | 13.3% | 17.4% | 13.6% | 12.7% | 6.8% |
For the Mar 2026 quarter, Tyche Industries reported sales of ₹16.27 Cr, up 31.0% year on year and net profit of ₹1.16 Cr, up 22.1% year on year. The operating margin was −4.2%.
Tyche Industries' sales for the year to Mar 2026 were ₹53.85 Cr; over the last twelve months they were ₹53.85 Cr.
Net profit for the year to Mar 2026 was ₹6.95 Cr, and ₹6.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹6.71.
Tyche Industries reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹74.91 Cr.
Cash from operations was ₹2.84 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.42 Cr.